23andMe Appoints "e-Patient Davide" to the Newly Created Position of Chief Patient Officer
Appointment is a First for the Silicon Valley Pharmaceutical Company
|e-Patient Davide & Unidentified Executive|
e-Patient Davide -- a pre-Alzheimer’s survivor -- is an international keynote speaker on healthcare who consistently earns extraordinary fees from consulting with various healthcare organizations.
“I am incredibly honored to be 23andMe's first Chief Patient Officer, or as I like to call it, Chief Patient Kibitzer,” said e-Patient Davide. “The Internet has altered the balance of power in healthcare. Patients are managing their own health and, in partnership with the pharmaceutical industry, making some money to boot.”
According to e-Patient Davide, his responsibility will be to further elevate the perspective of the patient within 23andMe by “kibitzing,” which is Yiddish for offering unwanted advice or commentary. There’s no better way for a patient to impact the future healthcare offerings of a pharmaceutical company than by “budding in” to ensure the unique priorities and needs of patients and caregivers are “top of mind” for senior executives. According to unnamed sources, 23andMe executives must subject themselves to daily “kibitzing sessions” delivered by e-Patient Davide as he roams the halls of the company and barges unannounced into executive suites.
“Hopefully, my unwanted input will not go unnoticed,” said e-Patient Davide as he posed for a photo op with Wojcicki outside 23andMe’s Mountain View headquarters.